Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-07-14 Purchase |
2020-07-15 5:00 pm |
Poseida Therapeutics Inc. | PSTX | Murphy Sean Director 10% Owner |
10,000 | $16 | $160,000 | 9,198,125 (Indirect Direct) |
View |
| 2020-07-14 Purchase |
2020-07-15 5:00 pm |
Poseida Therapeutics Inc. | PSTX | Hirsch David Director |
250,000 | $16 | $4,000,000 | 2,714,245 (Indirect) |
View |
| 2020-07-14 Purchase |
2020-07-15 5:00 pm |
Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director |
10,000 | $16 | $160,000 | 10,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-07-14 Conversion |
2020-07-15 5:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
1,362,898 | $0 | 9,293,525 (Indirect) |
View |
| 2020-07-14 Conversion |
2020-07-15 5:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Murphy Sean Director 10% Owner |
20,645,718 | $0 | 9,198,125 (Indirect) |
View |
| 2020-07-14 Conversion |
2020-07-15 5:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Hirsch David Director |
5,537,159 | $0 | 2,714,245 (Indirect) |
View |
| 2020-07-09 Option Award |
2020-07-13 7:00 pm |
N/A 2030-07-08 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-07-09 Option Award |
2020-07-13 7:00 pm |
N/A 2030-07-08 |
Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-07-09 Option Award |
2020-07-13 7:00 pm |
N/A 2030-07-08 |
Poseida Therapeutics Inc. | PSTX | MACKEY CATHERINE J Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-07-09 Option Award |
2020-07-13 7:00 pm |
N/A 2030-07-08 |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CBO |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-07-09 Option Award |
2020-07-13 7:00 pm |
N/A 2030-07-08 |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Senior Vice President, Finance |
35,000 | $0 | 35,000 (Direct) |
View |
| 2020-07-09 Option Award |
2020-07-13 7:00 pm |
N/A 2030-07-08 |
Poseida Therapeutics Inc. | PSTX | Hirsch David Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-07-09 Option Award |
2020-07-13 7:00 pm |
N/A 2030-07-08 |
Poseida Therapeutics Inc. | PSTX | Murphy Sean Director 10% Owner |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2020-07-13 06:02 am |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | NOVARTIS PHARMA AG NOVARTIS AG 10% Owner |
0 | $0 | 5,908,089 (Direct) |
View |
Ownership |
2020-07-09 6:20 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Malin Corp plc 10% Owner |
0 | $0 | 9,188,125 (Direct) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A 2029-01-30 |
Poseida Therapeutics Inc. | PSTX | MACKEY CATHERINE J Director |
0 | $0 | 48,114 (Direct) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Murphy Sean Director 10% Owner |
0 | $0 | 9,188,125 (Indirect) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
0 | $0 | 10,344,981 (Direct) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Hirsch David Director |
0 | $0 | 2,464,245 (Indirect) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
0 | $0 | 360,865 (Direct) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A 2029-01-30 |
Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director |
0 | $0 | 48,114 (Direct) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A 2028-07-16 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
0 | $0 | 48,114 (Direct) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Senior Vice President, Finance |
0 | $0 | 116,838 (Direct) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A 2029-10-16 |
Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer |
0 | $0 | 128,307 (Direct) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A 2028-03-01 |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CBO |
0 | $0 | 348,836 (Direct) |
View |